Over the past decade, drug-eluting stents (DES) have greatly transformed the field of interventional cardiology. Generally, three components are included in a DES system: a metal stent platform ...

Boston Scientific has recently reported the results of the Optical Coherence Tomography Drug Eluting Stent Investigation (OCTDESI)trial; part of the JACTAX stent program. [30] The JACTAX stent con ...

Compared with a contemporary zotarolimus drug-eluting stent, a coronary bioadaptor system is noninferior among patients with CAD receiving PCI.

You’ll usually need to continue dual antiplatelet drug therapy for a year after a drug-eluting stent placement and a month after a bare-metal stent placement. Drug-eluting stents are a newer ...

The company is one of the leading players in the interventional cardiology market with its coronary stent product offerings. Boston Scientific markets a broad portfolio of internally-developed and ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

Additionally, the INFINITY-SWEDEHEART RCT data were published concurrently in The Lancet, in a peer-reviewed article entitled, “Bioadaptor implant versus contemporary drug-eluting stent in ...

Solaris Endovascular today announced its formation to develop solutions for dialysis access and treating peripheral artery ...

Opens in a new tab or window For percutaneous coronary intervention (PCI) on de novo lesions, the DynamX bioadaptor not only matched drug-eluting stents (DES) in early performance but seemed to ...

prior to second generation drug-eluting stent implantation and optimization. Procedural complications were largely similar between groups. The primary imaging endpoint consisted of the acute post ...

The global Implantable Drug Eluting Devices Market is poised for substantial growth, projected to expand at a compound annual growth rate (CAGR) of 6.0% from 2022 to 2029. The market, valued at ...